Psychiatry Month in Review: July 2024

This Month in Review for July encompasses the top US Food and Drug Administration (FDA) news, pipeline updates, and discovered associations in the psychiatry field. The recap also captures insights from psychiatry experts on topics ranging from schizophrenia to PTSD. On the latter subject, the Month in Review includes commentary from a psychiatry expert on the potential game-changer MDMA-assisted therapy, with an FDA decision now less than a month away in August.